Stocks

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks Top Stock Websites Top Gainers/ Losers/ Active Stocks Dividend Stocks ChatGPT Stocks

ETFs

ETF Center Top ETFs by Upside

Top ETFs by Smart Score Top Gainers/ Losers/ Active ETFs

Crypto

Crypto Center Bitcoin

Options

Options Market Overview Unusual Options Activity

Most Active Options Options Volume Leaders

Research Tools

Stock Screener ETF Screener

Compare Stocks Compare ETFs Trending Stocks Technical Analysis Screener Penny Stock Screener Daily Analyst Ratings Daily Insider Trading Tracker

Calendars

Earnings Calendar Dividend Calendar Economic Calendar IPO Calendar Market Holidays

Calculators

Dividend Calculator Dividend Yield Calculator Options Profit Calculator

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Personal Finance Center Mortgages Loans Investing & Retirement Spending & Savings

Calculators

401k Retirement Calculator

Mortgage Calculator

Compound Interest Calculator Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks TipRanks Community Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

Follow Us

TOOLS

Earnings Calendar

STOCKS

ADVANCED RESEARCH

TipRanks Premium

Invest Like a Pro with Unique Data & Simplifed ToolsTry Now

Stocks

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks

Top Stock Websites

Top Gainers/ Losers/ Active Stocks

Dividend Stocks

ETFs

Top ETFs by Upside

Top ETFs by Smart Score

Top Gainers/ Losers/ Active ETFs

Options

Options Market Overview

Unusual Options Activity

Most Active Options

Options Volume Leaders

Crypto

Research Tools

Trending Stocks

Technical Analysis Screener

Penny Stock Screener

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Plans & Pricing

Education

About Us

TipRanks Community

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

GoodRx Holdings (GDRX)

NASDAQ:GDRX

US Market

GDRX

GoodRx Holdings

Analyst Forecasts

Technical Analysis

News & Insights

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

GoodRx Holdings (GDRX) Stock Forecast & Price Target

944 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GDRX Analyst Ratings

Moderate Buy

3 Buy

8 Hold

0 Sell

Based on 11 analysts giving stock ratings to

GoodRx

Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GDRX Stock 12 Months Forecast

Average Price Target

$6.65

▲(9.20% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for GoodRx Holdings in the last 3 months. The average price target is $6.65 with a high forecast of $12.00 and a low forecast of $5.00. The average price target represents a 9.20% change from the last price of $6.09.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"$3","8":"$8","13":"$13","5.5":"$5.5","10.5":"$10.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":12,"label":{"className":"overflowvisible_force","align":"right","x":60,"y":-17.5,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$12.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.65,"label":{"className":"overflowvisible_force","align":"right","x":60,"y":-7.5,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$6.65</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5,"label":{"className":"overflowvisible_force","align":"right","x":60,"y":2.5,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$5.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,5.5,8,10.5,13],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2023","6":"Jun<br/>2023","9":"Sep<br/>2023","12":"Dec<br/>2023","25":"Dec<br/>2024"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.37,6.803076923076923,7.236153846153846,7.6692307692307695,8.102307692307692,8.535384615384615,8.968461538461538,9.401538461538461,9.834615384615384,10.267692307692307,10.70076923076923,11.133846153846154,11.566923076923077,{"y":12,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.37,6.391538461538461,6.413076923076924,6.434615384615385,6.456153846153846,6.477692307692308,6.49923076923077,6.520769230769231,6.542307692307692,6.563846153846154,6.585384615384616,6.606923076923077,6.628461538461539,{"y":6.65,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.37,6.264615384615385,6.15923076923077,6.053846153846154,5.9484615384615385,5.843076923076923,5.737692307692308,5.632307692307692,5.526923076923077,5.421538461538462,5.3161538461538465,5.21076923076923,5.105384615384615,{"y":5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.33,"date":1669939200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.84,"date":1672963200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5.77,"date":1675382400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.92,"date":1677801600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5.9,"date":1680825600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.6,"date":1683244800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5.39,"date":1685664000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5.32,"date":1688688000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":9.12,"date":1691107200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6.55,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.15,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.37,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.37,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$12.00

Average Price Target$6.65

Lowest Price Target$5.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

xxxxxxxxxxxxxxxxxx

J.P. Morgan

Reiterated

11/17/23

xxxxxxxxxxxxxxxxxx

Goldman Sachs

Reiterated

11/10/23

xxxxxxxxxxxxxxxxxx

Morgan Stanley

Reiterated

11/10/23

xxxxxxxxxxxxxxxxxx

Deutsche Bank

Reiterated

11/10/23

xxxxxxxxxxxxxxxxxx

TD Cowen

Reiterated

11/10/23

xxxxxxxxxxxxxxxxxx

Wells Fargo

Reiterated

11/10/23

xxxxxxxxxxxxxxxxxx

Bank of America Securities

Bank of America Securities

Reiterated

11/10/23

xxxxxxxxxxxxxxxxxx

D.A. Davidson

Reiterated

11/09/23

xxxxxxxxxxxxxxxxxx

KeyBanc

Reiterated

11/09/23

xxxxxxxxxxxxxxxxxx

RBC Capital

Reiterated

11/09/23

Truist Financial Analyst forecast on GDRX

Jailendra Singh

Truist Financial

$5.50

Hold

-9.69%

Downside

Reiterated

11/09/23

GoodRx Holdings Revenue Challenges and Growth Prospects: A Hold Rating Analysis

Jefferies Analyst forecast on GDRX

Glen Santangelo

Jefferies

$7.00

Buy

14.94%

Upside

Reiterated

08/25/23

Wall Street Analysts Are Bullish on Top Healthcare Picks

Vikram Kesavabhotla

Robert W. Baird

$8.00

Hold

31.36%

Upside

Reiterated

08/15/23

GoodRx Holdings Inc. (GDRX) PT Raised to $8 at BairdBaird analyst Vikram Kesavabhotla raised the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $8.00 (from $5.00) while maintaining a Neutral rating.

Evercore ISI Analyst forecast on GDRX

Evercore ISI

$10.00

Hold

64.20%

Upside

Reiterated

08/10/23

GoodRx price target raised to $10 from $7 at Evercore ISIGoodRx price target raised to $10 from $7 at Evercore ISI

Guggenheim

$10.00

Buy

64.20%

Upside

Reiterated

08/10/23

GoodRx price target raised to $10 from $8 at GuggenheimGoodRx price target raised to $10 from $8 at Guggenheim

Best Analysts Covering GoodRx Holdings

Which Analyst Should I Follow If I Want to Buy GDRX and Sell After:

1 Month

Daniel GrosslightCiti

Success Rate

5/8 ratings generated profit

Average Return

+1.57%

assigned a buy rating 4 months ago

Copying Daniel Grosslight's trades and holding each position for 1 Month would result in 62.50% of your transactions generating a profit, with an average return of +1.57% per trade.

dummydummy

Success Rate

0/0 ratings generated profit

Average Return

0.00%

a rating ―

Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.

Premium Content

Find out which analyst has the highest Average Return & Success Rate

3 Months

Daniel GrosslightCiti

Success Rate

6/8 ratings generated profit

Average Return

+11.76%

assigned a buy rating 4 months ago

Copying Daniel Grosslight's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +11.76% per trade.

dummydummy

Success Rate

0/0 ratings generated profit

Average Return

0.00%

a rating ―

Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.

Premium Content

Find out which analyst has the highest Average Return & Success Rate

1 Year

Daniel GrosslightCiti

Success Rate

7/8 ratings generated profit

Average Return

+19.80%

assigned a buy rating 4 months ago

Copying Daniel Grosslight's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +19.80% per trade.

2 Years

Daniel GrosslightCiti

Success Rate

7/8 ratings generated profit

Average Return

+21.26%

assigned a buy rating 4 months ago

Copying Daniel Grosslight's trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +21.26% per trade.

dummydummy

Success Rate

0/0 ratings generated profit

Average Return

0.00%

a rating ―

Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.

Premium Content

Find out which analyst has the highest Average Return & Success Rate

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxxxxxxxxxxxxxx

xxxxxxxxxxxxxxx

xxxxxxxxxxxxxxx

xxxxxxxxxxxxxxx

xxxxxxxxxxxxxxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

GDRX Financial Forecast

GDRX Earnings Forecast

Next quarter’s earnings estimate for GDRX is $0.06 with a range of $0.01 to $0.07. The previous quarter’s EPS was $0.06. GDRX beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.67% of the time in the same period. In the last calendar year GDRX has Outperformed its overall industry.

Next quarter’s earnings estimate for GDRX is $0.06 with a range of $0.01 to $0.07. The previous quarter’s EPS was $0.06. GDRX beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.67% of the time in the same period. In the last calendar year GDRX has Outperformed its overall industry.

GDRX Sales Forecast

Next quarter’s sales forecast for GDRX is $190.84M with a range of $188.52M to $192.00M. The previous quarter’s sales results were $179.96M. GDRX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.45% of the time in the same period. In the last calendar year GDRX has Outperformed its overall industry.

Next quarter’s sales forecast for GDRX is $190.84M with a range of $188.52M to $192.00M. The previous quarter’s sales results were $179.96M. GDRX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.45% of the time in the same period. In the last calendar year GDRX has Outperformed its overall industry.

GDRX Analyst Recommendation Trends

In the current month, GDRX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GDRX average analyst price target in the past 3 months is $6.65

In the current month, GDRX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GDRX average analyst price target in the past 3 months is $6.65

GDRX Stock Forecast FAQ

What is GDRX’s average 12-month price target, according to analysts?

Based on analyst ratings, GoodRx Holdings’s 12-month average price target is $6.65.

What is GDRX’s upside potential, based on the analysts’ average price target?

GoodRx Holdings has 9.20% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GDRX a Buy, Sell or Hold?

GoodRx Holdings has a conensus rating of Moderate Buy which is based on 3 buy ratings, 8 hold ratings and 0 sell ratings.

What is GoodRx Holdings’s price target?

The average price target for GoodRx Holdings is $6.65. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $12.00 ,the lowest forecast is $5.00. The average price target represents 9.20% Increase from the current price of $6.09.

What do analysts say about GoodRx Holdings?

GoodRx Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of GDRX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing